Recommended Pages at biohealthinvestor.com
Alkermes & Elan, Game-Changing Deal For Both Companies (ALKS, ELN, JNJ, ACOR, AMLN, LLY) : BioHealth Investor
biohealthinvestor.com — “Alkermes & Elan, Game-Changing Deal For Both Companies (ALKS, ELN, JNJ, ACOR, AMLN, LLY) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on May 10, 2011 at 2:04 am By:
Alkermes & Elan, Game-Changing Deal For Both Companies (ALKS, ELN, JNJ, ACOR, AMLN, LLY): The biotech sector has... http://bit.ly/jH1i0z
When Analysts Expect Shares to More Than Double (VICL, PRAN, BMY, AMGN) : BioHealth Investor
biohealthinvestor.com — “When Analysts Expect Shares to More Than Double (VICL, PRAN, BMY, AMGN) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on April 27, 2011 at 6:50 am By:
When Analysts Expect Shares to More Than Double (VICL, PRAN, BMY, AMGN): We recently have picked back up on sear... http://bit.ly/fqpA9F
Opexa’s Surge Brings More MS Treatment Hope (OPXA, BIIB, NVS) : BioHealth Investor
biohealthinvestor.com — “Opexa’s Surge Brings More MS Treatment Hope (OPXA, BIIB, NVS) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on January 7, 2011 at 1:27 am By:
Opexa’s Surge Brings More MS Treatment Hope (OPXA, BIIB, NVS): Opexa Therapeutics, Inc. (NASDAQ: OPXA) is on f... http://bit.ly/dOEQ9v
Geron Takes Breast Cancer Stem Cell Study to Phase II (GERN) : BioHealth Investor
biohealthinvestor.com — “Geron Takes Breast Cancer Stem Cell Study to Phase II (GERN) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on December 2, 2010 at 1:14 pm By:
Geron Takes Breast Cancer Stem Cell Study to Phase II (GERN) http://bit.ly/hZG0Jm
Outlook 2011: 2010 BioHealth Winners Part 1 (ARIA, CHTP, CYCC, ENMD, EXAS, EXEL, FOLD, IDIX) : BioHealth Investor
biohealthinvestor.com — “Outlook 2011: 2010 BioHealth Winners Part 1 (ARIA, CHTP, CYCC, ENMD, EXAS, EXEL, FOLD, IDIX) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on December 1, 2010 at 3:06 am By:
Outlook 2011: 2010 BioHealth Winners Part 1 (ARIA, CHTP, CYCC, ENMD, EXAS, EXEL, FOLD, IDIX): 2010 has so far la... http://bit.ly/h1BkQu
MELA Gets New Signs of Life After FDA Panel (MELA) : BioHealth Investor
biohealthinvestor.com — “MELA Gets New Signs of Life After FDA Panel (MELA) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on November 19, 2010 at 1:45 pm By:
MELA Gets New Signs of Life After FDA Panel (MELA) http://bit.ly/dtoHms
Dendreon One Step Closer to Provenge Approval Expansion (DNDN) : BioHealth Investor
biohealthinvestor.com — “Dendreon One Step Closer to Provenge Approval Expansion (DNDN) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on November 18, 2010 at 2:51 pm By:
Dendreon One Step Closer to Provenge Approval Expansion (DNDN) http://bit.ly/aIy9zQ
More Big Problems For Obesity Drugs (ABT, VVUS, ARNA, OREX) : BioHealth Investor
biohealthinvestor.com — “More Big Problems For Obesity Drugs (ABT, VVUS, ARNA, OREX) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on October 9, 2010 at 3:49 pm By:
More Big Problems For Obesity Drugs (ABT, VVUS, ARNA, OREX): Abbott Laboratories (NYSE: ABT) is the latest casualt... http://bit.ly/9k177b
Promising Data In New Breast Cancer Treatment Candidate (IMGN) : BioHealth Investor
biohealthinvestor.com — “Promising Data In New Breast Cancer Treatment Candidate (IMGN) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on October 8, 2010 at 5:44 pm By:
Promising Data In New Breast Cancer Treatment Candidate (IMGN) http://bit.ly/9z5Afn
Good News on Thyroid Cancer War (OXGN) : BioHealth Investor
biohealthinvestor.com — “Good News on Thyroid Cancer War (OXGN) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on September 13, 2010 at 1:40 pm By:
Good News on Thyroid Cancer War (OXGN) http://bit.ly/dAjd3w
Questor Meets FDA Snag (QCOR) : BioHealth Investor
biohealthinvestor.com — “Questor Meets FDA Snag (QCOR) : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on September 9, 2010 at 1:15 pm By:
Questor Meets FDA Snag (QCOR): Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) was a mere 48 hours away from an FDA ... http://bit.ly/cDlCrH
Roche Cancer Drug Does Not Receive FDA Approval : BioHealth Investor
biohealthinvestor.com — “Roche Cancer Drug Does Not Receive FDA Approval : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on August 30, 2010 at 5:40 pm By:
Roche Cancer Drug Does Not Receive FDA Approval http://bit.ly/9dW49w
FDA Shoots Down Jazz Pharmaceuticals’ Fibromyalgia Treatment : BioHealth Investor
biohealthinvestor.com — “FDA Shoots Down Jazz Pharmaceuticals’ Fibromyalgia Treatment : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on August 25, 2010 at 11:38 pm By:
FDA Shoots Down Jazz Pharmaceuticals’ Fibromyalgia Treatment: Jazz Pharmaceuticals (NASDAQ: JAZZ) lost one of it... http://bit.ly/9hqbin
DepoMed Dodges Patent Infringement Lawsuit : BioHealth Investor
biohealthinvestor.com — “DepoMed Dodges Patent Infringement Lawsuit : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on August 5, 2010 at 6:22 pm By:
DepoMed Dodges Patent Infringement Lawsuit: DepoMed Inc. (NASDAQ: DEPO) was up $0.47 (16.61%) today to $3.30 on ne... http://bit.ly/bkQBvX
New AstraZeneca Drug Does Well With FDA : BioHealth Investor
biohealthinvestor.com — “New AstraZeneca Drug Does Well With FDA : BioHealth Investor” View full resource at biohealthinvestor.com
Most Recently Shared on July 27, 2010 at 5:29 pm By:
New AstraZeneca Drug Does Well With FDA http://bit.ly/aZpyGi
